US · SYF · FINANCIAL - CREDIT SERVICES
Synchrony Financial (SYF) intrinsic value and stock valuation
$67.76as of 2026-11-21 · Mkt cap 25.79B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Synchrony Financial DCF and intrinsic value
InvestorsCraft values SYF with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from SYF’s statements →
Synchrony Financial Graham Number
Graham Number: $102.29d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Morgan Stanley (MS) $165.67
- Truist Financial Corporation (TFC) $45.81
- Fifth Third Bancorp (FITB) $49.39
- ORIX Corporation (IX) $32.01
- KB Financial Group Inc. (KB) $108.79
- M&T Bank Corporation (MTB) $208.30
- Shinhan Financial Group Co., Ltd. (SHG) $62.51
- Banco Bradesco S.A. (BBDO) $2.09
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $19.1B | $20.8B | $17.3B | $13.2B | $11.2B |
| Operating income | $4.62B | $4.55B | $2.9B | $3.96B | $5.5B |
| Net income | $3.55B | $3.5B | $2.24B | $3.02B | $4.22B |
| EPSd | $9.93M | $8.73M | $5.28M | $6.24M | $7.41M |
| Operating cash flow | $9.85B | $9.85B | $8.59B | $6.69B | $7.1B |
| Capital expenditure | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free cash flow | $9.85B | $9.85B | $8.59B | $6.69B | $7.1B |
| Total assets | $119.1B | $119.5B | $117.5B | $104.6B | $95.7B |
| Total debt | $15.2B | $15.5B | $16B | $14.2B | $14.5B |
| Net debt | $209M | $751M | $1.72B | $3.9B | $6.17B |
| Total equity | $16.8B | $16.6B | $13.9B | $12.9B | $13.7B |
| Cash and short-term investments | $17.3B | $17.8B | $18.1B | $15.2B | $13.6B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $19.1B | $20.8B | $17.3B | $13.2B | $11.2B |
| Cost of revenue | $9.36B | $11.4B | $9.68B | $4.9B | $1.76B |
| Gross profit | $9.76B | $9.39B | $7.66B | $8.3B | $9.47B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $2.6B | $2.35B | $2.41B | $2.17B | $1.99B |
| Other expenses | $2.53B | $2.49B | $2.35B | $2.17B | $1.98B |
| Operating expenses | $5.14B | $4.84B | $4.76B | $4.34B | $3.96B |
| Cost and expenses | $14.5B | $16.2B | $14.4B | $9.23B | $5.72B |
| Interest income | $22.6B | $22.6B | $20.7B | $17.1B | $15.3B |
| Interest expense | $4.14B | $4.63B | $3.71B | $1.52B | $1.03B |
| Depreciation and amortization | $514M | $481M | $458M | $419M | $390M |
| Ebitda | $5.14B | $5.03B | $3.36B | $4.38B | $5.89B |
| Operating income | $4.62B | $4.55B | $2.9B | $3.96B | $5.5B |
| Total other income/expenses, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income before tax | $4.62B | $4.55B | $2.9B | $3.96B | $5.5B |
| Income tax expense | $1.07B | $1.05B | $666M | $946M | $1.28B |
| Net income | $3.55B | $3.5B | $2.24B | $3.02B | $4.22B |
| Weighted average shares outstanding | $357.8M | $396.5M | $421.2M | $480.4M | $564.6M |
| Weighted average diluted shares outstanding | $357.8M | $400.6M | $423.5M | $483.4M | $569.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $17.3B | $17.8B | $18.1B | $15.2B | $13.6B |
| Net receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $17.3B | $17.8B | $18.1B | $15.2B | $13.6B |
| Property, plant and equipment, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill and intangible assets | $2.62B | $2.13B | $1.83B | $1.85B | $2.27B |
| Long-term investments | $93.4B | $104.7B | $103.2B | $92.5B | $85.1B |
| Total non-current assets | $101.8B | $101.7B | $99.4B | $89.4B | $82.1B |
| Total assets | $119.1B | $119.5B | $117.5B | $104.6B | $95.7B |
| Accounts payable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Short-term debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $81.1B | $82.1B | $81.2B | $77.5B | $67.6B |
| Long-term debt | $15.2B | $15.5B | $16B | $14.2B | $14.5B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $21.2B | $20.8B | $22.4B | $14.2B | $14.5B |
| Capital lease obligations | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total liabilities | $102.3B | $102.9B | $103.6B | $91.7B | $82.1B |
| Common stock | $1M | $1M | $1M | $1M | $1M |
| Retained earnings | $24.6B | $21.6B | $18.7B | $16.7B | $14.2B |
| Accumulated other comprehensive income (loss) | -$-48M | -$-59M | -$-68M | -$-125M | -$-69M |
| Total equity | $16.8B | $16.6B | $13.9B | $12.9B | $13.7B |
| Total investments | $95.7B | $107.8B | $107B | $97.3B | $90.4B |
| Total debt | $15.2B | $15.5B | $16B | $14.2B | $14.5B |
| Net debt | $209M | $751M | $1.72B | $3.9B | $6.17B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $3.55B | $3.5B | $2.24B | $3.02B | $4.22B |
| Depreciation and amortization | $514M | $481M | $458M | $419M | $390M |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-161M | -$-205M | -$-345M | -$-269M | $1.02B |
| Accounts receivable | -$-598M | $33M | -$-645M | -$-197M | $424M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash provided by operating activities | $9.85B | $9.85B | $8.59B | $6.69B | $7.1B |
| Investments in property, plant and equipment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acquisitions, net | -$-161M | -$-1.44B | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | -$-4.85B | -$-8.9B | -$-14.23B | -$-10.23B | -$-4.81B |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-2.94B | -$-1.01B | -$-1.11B | -$-3.32B | -$-2.88B |
| Dividends paid | -$-510M | -$-470M | -$-448M | -$-476M | -$-542M |
| Net cash used for financing activities | -$-4.74B | -$-611M | $9.63B | $5.28B | -$-5.2B |
| Net change in cash | $262M | $334M | $3.99B | $1.74B | -$-2.92B |
| Cash at end of period | $15B | $14.8B | $14.4B | $10.4B | $8.69B |
| Operating cash flow | $9.85B | $9.85B | $8.59B | $6.69B | $7.1B |
| Capital expenditure | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free cash flow | $9.85B | $9.85B | $8.59B | $6.69B | $7.1B |
Line items
Line items
Line items
About Synchrony Financial
Synchrony Financial, along with its various subsidiaries, functions as a leading provider of consumer financial services across the United States. The company offers a comprehensive range of credit products, encompassing diverse credit card options such as private label, co-branded, and general-purpose cards, alongside commercial credit solutions and consumer installment loans for both short and long durations. Additionally, Synchrony provides consumer banking services, including a variety of deposit products like certificates of deposit, individual retirement accounts, money market accounts, and savings accounts. These are made available to both individual consumers and commercial entities, with deposits also accepted via external securities brokerage firms. Beyond core credit and banking, Synchrony extends debt cancellation programs to its credit card clientele through online, mobile, and direct mail channels. It is also a significant player in specialized financing, offering healthcare payment and funding solutions under its CareCredit, Pets Best, and Walgreens brands. The firm further provides payment and financing options to industries like apparel, specialty retail, outdoor, music, and luxury, as well as point-of-sale consumer financing for audiology products and dental services. Synchrony delivers its credit offerings through collaborative programs established with a broad network of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers. Its deposit products reach customers through various avenues, including digital and print media. The company's services cater to a wide array of sectors, including digital, health and wellness, retail, home, auto, powersports, jewelry, and pet industries, among others. Established in 1932, Synchrony Financial's corporate headquarters are located in Stamford, Connecticut.
- CEO
- Brian D. Doubles
- Employees
- 20K
- Beta
- 1.31
Included in
Explore
Frequently asked questions
What is the intrinsic value of Synchrony Financial (SYF)?
Synchrony Financial (SYF) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is SYF undervalued?
SYF trades at a price of $67.76 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.